Sharemaestro Newsreel

Takeda Pharmaceutical (TAK) holder Elaine Shannon plans sale of 20,363 ADSs

Elaine Shannon, a shareholder of Takeda Pharmaceutical Company Limited (TAK), has filed a notice of proposed sale for 20,363 American Depositary Shares (ADSs). The sale, valued at $355,334.35, is anticipated to occur on August 11, 2026, via Interactive Brokers LLC on the NYSE. These …

Hims & Hers' shift to branded obesity drugs drives wider quarterly loss

Phibro Animal Health (PAHC) grants 2,716 RSUs to director Jonathan Bendheim

Phibro Animal Health (PAHC) director Jonathan Bendheim was granted 2,716 restricted stock units (RSUs) on August 6, 2026. These RSUs represent a contingent right to receive one share of Class A Common Stock each, and they will vest in substantially equal installments on the …

Phibro Animal Health (NASDAQ: PAHC) awards 2,478 RSUs to senior legal officer

Phibro Animal Health Corp (NASDAQ: PAHC) has awarded 2,478 Restricted Stock Units (RSUs) to Judith Weinstein, its Senior Vice President and General Counsel. This grant increases her direct holdings to 5,453 shares. The RSUs will vest in substantially equal installments over three years, beginning …

Phibro Animal Health (NASDAQ: PAHC) CFO receives 3,334-share restricted stock grant

Phibro Animal Health (NASDAQ: PAHC) CFO David Glenn was granted 3,334 restricted stock units (RSUs). These RSUs, which represent Class A Common Stock, were awarded at a price of $0.00 per share and will vest in three equal annual installments starting August 1, 2026, …

Phibro Animal Health (PAHC) awards 1,547 RSUs to SVP of Human Resources

Phibro Animal Health (PAHC) awarded 1,547 restricted stock units (RSUs) to Lisa Ann Escudero, SVP of Human Resources, on August 6, 2026. These RSUs will vest in three equal installments on the first three anniversaries of August 1, 2026, contingent on her continued employment. …

Phibro Animal Health (PAHC) grants 11,699 RSUs to President and CEO

Phibro Animal Health (PAHC) reported that its President and CEO, Daniel M. Bendheim, was granted 11,699 restricted stock units (RSUs). These RSUs represent a contingent right to receive one share of Class A Common Stock each, vesting in three equal annual installments beginning August …

Phibro Animal Health (NASDAQ: PAHC) awards 1,503 RSUs to VP Finance

Phibro Animal Health Corp (NASDAQ: PAHC) has awarded its VP Finance and Treasurer, Patrick Rodriguez, 1,503 restricted stock units (RSUs) representing Class A Common Stock. These RSUs will vest in substantially equal installments over the first three anniversaries of August 1, 2026, contingent on …

Phibro Animal Health (PAHC) grants 12,103 RSUs to Executive Chairman Bendheim

Phibro Animal Health Corp. (PAHC) Executive Chairman and 10% owner Jack Bendheim was granted 12,103 restricted stock units (RSUs). These RSUs, each representing one share of Class A Common Stock, will vest in equal installments over the first three anniversaries of August 1, 2026, …

Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates

Harrow (HROW) reported a Q2 loss of $0.34 per share, missing the Zacks Consensus Estimate of a $0.23 loss, and revenues of $70.66 million, also below estimates. The company's shares have underperformed the S&P 500 this year, and its current Zacks Rank is #3 …

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

Revenue of approximately $753 million, up 38% year-over-year in Q2 2026 Subscribers grew to nearly 2.9 million, up 19% year-over-year in Q2 2026 Raises full year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion and updates Adjusted EBITDA guidance to …

Scynexis (NASDAQ: SCYX) lifts cash and pipeline with Q2 2026 moves

Hers Health, Inc. Reports Second Quarter 2026 Financial Results

Hims & Hers Health, Inc. announced strong financial results for Q2 2026, with revenue up 38% year-over-year to $753 million and subscribers growing to nearly 2.9 million. The company raised its full-year 2026 revenue guidance to $3.1 billion to $3.3 billion and updated its …

Aurora Cannabis Inc. stock falls Monday, underperforms market

Aurora Cannabis Inc. (ACB) shares fell by 3.34% to $2.89 on Monday, underperforming the broader market. The NASDAQ Composite Index and Dow Jones Industrial Average also experienced declines, falling 0.32% and 0.11% respectively. This drop ended a three-day winning streak for Aurora Cannabis Inc.

Aurora Cannabis Shareholders Back Board Slate, Auditor and Say-on-Pay at August AGM

Aurora Cannabis shareholders approved all governance resolutions at their August 7, 2026, annual general meeting, including fixing the board size at five directors, reappointing Ernst & Young, and endorsing executive compensation. Director nominees, including CEO Miguel Martin, received strong majority support, with votes generally …

Harrow adds TYRVAYA's global rights to dry eye portfolio

Harrow is expanding its dry eye product portfolio by acquiring the global rights to TYRVAYA (varenicline solution) nasal spray from Viatris, Inc. This FDA-approved nasal spray, indicated for dry eye disease, was originally developed by Oyster Point Pharma. The deal involves a $30 million …

Trulieve Cannabis (TRLV) Could Be 55% Undervalued On Weak Q2 Earnings

Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study

Aquestive Therapeutics (AQST) announced positive results from human factors and pharmacokinetic validation studies for its Anaphylm sublingual film, a severe allergy treatment. These studies address prior FDA feedback, demonstrating significant improvements in product usability and effective drug delivery even with slight misplacement. The company …

Is Neurocrine Biosciences (NBIX) Fully Valued As It Enters Phase 1 Obesity Testing?

Neurocrine Biosciences (NBIX) has commenced a Phase 1 study for its obesity treatment candidate, NBIP 1968, following positive Q2 and H1 2026 financial results. Despite recent stock momentum and a current share price of $163.41, Simply Wall St's analysis suggests the company might be …

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Down - Time to Sell?

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho Corporation QDEL delivered adjusted earnings per share (EPS) of 13 cents in second-quarter 2026, up 8.3% year over year. The figure beat the Zacks Consensus Estimate by 425%. The adjustments include expenses related to the amortization of intangibles, acquisition and integration costs, among …

Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline

Integer Holdings Corporation ITGR delivered adjusted earnings per share (EPS) of $1.60 in the second quarter of 2026, up 3.2% year over year. The figure beat the Zacks Consensus Estimate by 15.9%. The adjustments include expenses related to the amortization of intangible assets and …

Cronos Group Inc. stock falls Monday, underperforms market

Cronos Group Inc. (CRON) stock decreased by 3.23% to $3.00 on Monday, underperforming the broader market. This drop ended a two-day winning streak for the company's shares. The NASDAQ Composite Index also fell 0.32%, and the Dow Jones Industrial Average fell 0.11%.

ANIP Tops Q2 Earnings, Stock Down on Cortrophin Sales View Cut

ANI Pharmaceuticals ANIP reported second-quarter 2026 adjusted EPS of $2.21, beating the Zacks Consensus Estimate of $2.01. The reported figure rose 23% year over year, driven by higher sales during the quarter. Quarterly revenues totaled $266 million, up 26% from the year-ago period. The …

Tilray Brands to cease production at US brewery Terrapin

Tilray Brands will cease brewing operations at its Terrapin Beer Co. facility in Athens, Georgia, by September 25, 2026, as part of a cost-cutting initiative called 'Project 420'. The taproom and other operations at the site will remain open, and Terrapin will continue as …

Dr. Reddy’s (RDY) to end Novartis India brand deal after Sept. 2026

Dr. Reddy's Laboratories Limited announced the termination of its distribution and promotion agreement with Novartis India Limited, effective September 30, 2026. This decision follows a change in the controlling shareholding of Novartis India. Dr. Reddy's will continue to commercialize the covered brands until the …

Aquestive Therapeutics (NASDAQ:AQST) Shares Gap Up - Should You Buy?

Optimi Health Corp (CN:OPTI) Shares Under Pressure as Psychedelic Market Uncertainty and Development Risks Weigh on Sentiment

Optimi Health Corp (CN:OPTI) shares recently declined by 2.40% due to investor caution surrounding the psychedelic medicine market, regulatory uncertainties, and broader biotechnology sector volatility. The company, which manufactures and distributes pharmaceutical-grade psychedelic products like psilocybin, faces challenges in market adoption, funding, and competition. …

Evotec (NASDAQ:EVO) Shares Gap Up - Here's What Happened

Evotec (NASDAQ:EVO) shares gapped up before the market opened, opening at $2.10 after closing at $2.00, and last traded at $2.0950 on modest volume. Analyst sentiment for the Germany-based biotechnology company is mixed, with a consensus "Hold" rating and a $3.00 average price target, …

PRGO vs. NEOG: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. Everyone has their own methods …

OTLK Up More Than 300% in 3 Months: Here's What You Should Know

Shares of Outlook Therapeutics OTLK have witnessed a significant surge over the past three months, primarily driven by growing investor optimism related to the company's sole product, Lytenava, which is approved for the treatment of patients with wet age-related macular degeneration (wet AMD). OTLK's …

Key Earnings Reports Ahead

Last week was "Jobs Week," and the week before held the most recent Fed meeting on interest rates, along with several marquee names reporting quarterly earnings. This week, we pivot to "Inflation Week," with Wednesday and Thursday morning bringing new monthly price index data. …

Asian Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

Asian equities traded in the US as American depositary receipts opened the week slightly lower Monday morning, declining 0.14% to 3,019.02 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by brand platform 36Kr (KRKR) and video display maker LG …

Trading Week Awaits Inflation Reports Starting Wednesday

Monday, August 10th, 2026 Last week was "Jobs Week," and the week before held the most recent Fed meeting on interest rates, along with several marquee names reporting quarterly earnings. This week, we pivot to "Inflation Week," with Wednesday and Thursday morning bringing new …

Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months

Shares of Replimune Group REPL have surged nearly 223% over the past three months, as the company steadily advanced its lead oncolytic immunotherapy, RP1 (vusolimogene oderparepvec), toward regulatory approval and strengthened the broader pipeline. The rally has been driven primarily by a series of …

Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (NASDAQ:KNSA)

This article provides an overview of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) stock performance, financial actuals, and analyst estimates. It includes current stock price, historical highs and lows, volatility, market capitalization, and details on recent and upcoming earnings reports, revenue, and net income. The article …